Department of Psychology, Ludwig Maximilian University, Munich, Germany.
Zurich Center for Neuroeconomics, Department of Economics, University of Zurich, Zürich, Switzerland.
Elife. 2021 Nov 11;10:e71077. doi: 10.7554/eLife.71077.
Theoretical accounts distinguish between motivational ('wanting') and hedonic ('liking') dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Reducing opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. In contrast, reducing dopaminergic neurotransmission with amisulpride revealed no robust effects on behavior or neural activity. Our findings thus provide insights into how opioid receptors mediate neural connectivity related to specifically motivational, not hedonic, aspects of rewards.
理论解释将奖励的动机(“想要”)和享乐(“喜欢”)维度区分开来。先前的动物和人类研究将想要和喜欢与解剖学和神经化学上不同的大脑机制联系起来,但尚不清楚不同的大脑区域和神经递质系统如何在处理不同的奖励维度时相互作用。在这里,我们在一项随机、安慰剂对照、双盲临床试验中评估了阿片类受体和多巴胺受体激活的药理学干预如何调节人类对想要和喜欢的神经处理。用纳曲酮减少阿片受体的激活选择性地降低了对奖励的渴望,这在神经水平上反映为与安慰剂相比,纳曲酮下背外侧前额叶皮层和纹状体之间的耦合更强。相比之下,用氨磺必利减少多巴胺能神经传递没有显示出对行为或神经活动的强烈影响。因此,我们的研究结果提供了关于阿片受体如何介导与奖励的动机方面相关的神经连接的见解,而不是享乐方面。